Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES ORCHID PHARMA INDOCO REMEDIES/
ORCHID PHARMA
 
P/E (TTM) x 30.7 39.8 77.2% View Chart
P/BV x 3.0 7.3 41.1% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 INDOCO REMEDIES   ORCHID PHARMA
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-23
ORCHID PHARMA
Mar-23
INDOCO REMEDIES/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs423439 96.5%   
Low Rs308273 112.8%   
Sales per share (Unadj.) Rs181.1163.1 111.0%  
Earnings per share (Unadj.) Rs15.413.5 114.1%  
Cash flow per share (Unadj.) Rs23.127.0 85.7%  
Dividends per share (Unadj.) Rs2.250-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs111.5168.7 66.1%  
Shares outstanding (eoy) m92.1540.82 225.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.2 92.6%   
Avg P/E ratio x23.726.3 90.1%  
P/CF ratio (eoy) x15.813.2 119.9%  
Price / Book Value ratio x3.32.1 155.4%  
Dividend payout %14.60-   
Avg Mkt Cap Rs m33,68314,522 231.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,226654 493.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,6866,659 250.6%  
Other income Rs m24194 12.3%   
Total revenues Rs m16,7106,853 243.8%   
Gross profit Rs m2,8601,235 231.6%  
Depreciation Rs m706548 128.9%   
Interest Rs m250329 76.1%   
Profit before tax Rs m1,928552 349.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5050-   
Profit after tax Rs m1,423552 257.5%  
Gross profit margin %17.118.5 92.4%  
Effective tax rate %26.20-   
Net profit margin %8.58.3 102.8%  
BALANCE SHEET DATA
Current assets Rs m8,0825,010 161.3%   
Current liabilities Rs m4,2453,719 114.1%   
Net working cap to sales %23.019.4 118.6%  
Current ratio x1.91.3 141.3%  
Inventory Days Days2557 43.7%  
Debtors Days Days7681,180 65.1%  
Net fixed assets Rs m9,0557,242 125.0%   
Share capital Rs m184408 45.2%   
"Free" reserves Rs m10,0926,478 155.8%   
Net worth Rs m10,2766,886 149.2%   
Long term debt Rs m1,4351,488 96.4%   
Total assets Rs m17,13712,252 139.9%  
Interest coverage x8.72.7 324.8%   
Debt to equity ratio x0.10.2 64.6%  
Sales to assets ratio x1.00.5 179.2%   
Return on assets %9.87.2 135.7%  
Return on equity %13.88.0 172.6%  
Return on capital %18.610.5 176.7%  
Exports to sales %47.581.9 58.0%   
Imports to sales %11.537.6 30.6%   
Exports (fob) Rs m7,9195,452 145.3%   
Imports (cif) Rs m1,9172,501 76.7%   
Fx inflow Rs m7,9195,452 145.3%   
Fx outflow Rs m1,9172,726 70.3%   
Net fx Rs m6,0022,726 220.2%   
CASH FLOW
From Operations Rs m1,788183 975.2%  
From Investments Rs m-2,082-312 666.9%  
From Financial Activity Rs m228312 73.2%  
Net Cashflow Rs m-65183 -35.7%  

Share Holding

Indian Promoters % 58.7 69.8 84.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 18.6 114.0%  
FIIs % 1.7 4.1 40.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.3 30.2 136.8%  
Shareholders   32,600 36,931 88.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Indoco Remedies vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Indoco Remedies vs Orchid Pharma Share Price Performance

Period Indoco Remedies Orchid Pharma S&P BSE HEALTHCARE
1-Day 1.83% -3.34% -1.03%
1-Month -7.88% -10.25% -5.08%
1-Year 2.83% 156.65% 57.36%
3-Year CAGR 6.33% -17.17% 18.12%
5-Year CAGR 12.66% 169.61% 18.86%

* Compound Annual Growth Rate

Here are more details on the Indoco Remedies share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of Indoco Remedies hold a 58.7% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Indoco Remedies and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, Indoco Remedies paid a dividend of Rs 2.3 per share. This amounted to a Dividend Payout ratio of 14.6%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Indoco Remedies, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.